Fig. 1: Study design and metrics of the sequencing cohort.
From: Clinical application of whole-genome sequencing of solid tumors for precision oncology
a Flow diagram of the study protocol. b Technical success rate of the CancerVisionTM application in the clinical setting. c Tumor types enrolled in this study. d The distribution of the tumor cell fraction of cancer tissues estimated using WGS according to specimen type.
